Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WV › Ranson › NPI 1891722377
Hospital

Jefferson Memorial Hospital

Jefferson Memorial Hospital was paid $21.65M by Medicaid between Jan 2018 and Dec 2024, across 202 billing codes. Its largest line is 99284, emergency room visit (serious) — 8.6% of everything it billed.

33Billing provider infoJEFFERSON MEMORIAL HOSPITAL
RANSON, WV 25438
33aNPI1891722377assigned 06/28/2006
33bProvider typeCritical Access Hospital
28Total paid$21.65M
24GClaims345,550
24DCodes billed202
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in West Virginia

Rank by total paid#1 of 24
Median peer was paid$3.57M
This provider vs. median6.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201856,927$3.93M
201939,697$2.32M
202072,411$5.68M
202170,486$4.66M
202234,552$1.79M
202340,413$1.82M
2024incomplete31,064$1.45M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.6% 14,875 12,432 $1.85M
74177 Computed tomography, abdomen and pelvis; with contrast material 7.8% 2,420 2,136 $1.68M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.6% 15,853 13,704 $1.43M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.3% 7,728 6,119 $1.15M
80053 Comprehensive metabolic panel 4.5% 28,373 22,858 $978K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.0% 29,697 23,406 $862K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.7% 7,902 5,813 $810K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.7% 1,440 1,285 $807K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.0% 7,886 6,438 $642K
96361 Intravenous infusion, hydration; each additional hour 2.6% 4,966 3,733 $568K
70450 Computed tomography, head or brain; without contrast material 2.5% 2,360 2,113 $534K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.5% 10,013 8,099 $532K
190 more codes
71045 Radiologic examination, chest; single view 1.9% 6,081 $410K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 3,355 $396K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.6% 3,364 $356K
96375 Therapeutic injection; each additional sequential IV push 1.5% 6,254 $332K
87086 Culture, bacterial; quantitative colony count, urine 1.4% 9,491 $313K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.2% 2,027 $258K
71275 Computed tomographic angiography, chest, with contrast material 1.2% 468 $258K
36415 Collection of venous blood by venipuncture 1.2% 17,898 $252K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.1% 3,663 $246K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.1% 4,097 $239K
81001 1.1% 9,840 $238K
84484 1.1% 6,500 $235K
84443 Thyroid stimulating hormone (TSH) <1% 5,654 $198K
71046 Radiologic examination, chest; 2 views <1% 2,240 $187K
83690 <1% 5,130 $159K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,510 $157K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,407 $157K
80061 Lipid panel <1% 3,800 $152K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,243 $137K
85610 <1% 5,635 $135K
85730 <1% 4,823 $131K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 673 $130K
72125 Computed tomography, cervical spine; without contrast material <1% 404 $113K
83036 Hemoglobin; glycosylated (A1C) <1% 3,715 $111K
77067 Screening mammography, bilateral, including computer-aided detection <1% 540 $109K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,204 $105K
83605 <1% 3,002 $105K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 380 $104K
84702 <1% 2,872 $102K
76830 Ultrasound, transvaginal <1% 445 $101K
96376 <1% 1,662 $101K
G0378 Hospital observation service, per hour <1% 670 $100K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,255 $95K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,303 $95K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,503 $91K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 803 $91K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 399 $90K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,515 $89K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,584 $84K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 359 $82K
87186 <1% 2,525 $81K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 4,109 $80K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,475 $79K
93971 <1% 249 $78K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,483 $78K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,017 $78K
83880 <1% 2,462 $77K
81025 <1% 1,616 $75K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 754 $70K
80048 Basic metabolic panel (calcium, ionized) <1% 2,196 $68K
86803 <1% 1,219 $63K
82607 <1% 1,121 $63K
J0690 Injection, cefazolin sodium, 500 mg <1% 538 $61K
87040 <1% 1,455 $60K
84439 <1% 870 $59K
76801 <1% 201 $55K
71250 <1% 173 $54K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 482 $51K
87077 <1% 1,489 $50K
86850 <1% 1,271 $49K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 73 $48K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,330 $47K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,577 $47K
82728 <1% 688 $47K
83735 <1% 2,031 $43K
85379 <1% 812 $42K
86901 <1% 1,432 $41K
94760 <1% 1,162 $39K
87070 <1% 988 $39K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,056 $39K
88142 <1% 1,545 $38K
87340 <1% 942 $37K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 139 $34K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,270 $33K
86140 <1% 1,407 $32K
81003 <1% 1,508 $31K
J2550 Injection, promethazine hcl, up to 50 mg <1% 270 $31K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 647 $31K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 43 $31K
84703 <1% 427 $30K
72110 <1% 184 $29K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 659 $28K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 57 $28K
86900 <1% 1,432 $27K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 718 $27K
73562 <1% 285 $27K
84145 <1% 616 $25K
82570 <1% 730 $25K
85027 <1% 488 $25K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 101 $24K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 162 $23K
73630 <1% 224 $22K
87088 <1% 571 $21K
73610 <1% 214 $20K
74018 <1% 185 $20K
84466 <1% 334 $19K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 899 $19K
80179 <1% 224 $18K
86780 <1% 802 $18K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 856 $17K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 244 $16K
77063 Screening digital breast tomosynthesis, bilateral <1% 297 $15K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 12 $15K
J1650 Injection, enoxaparin sodium, 10 mg <1% 458 $15K
73030 <1% 149 $15K
85007 <1% 324 $14K
83540 <1% 373 $14K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 174 $14K
82803 <1% 254 $12K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 812 $11K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 68 $11K
72131 <1% 26 $11K
94644 <1% 150 $11K
86762 <1% 289 $10K
94664 <1% 214 $9K
73130 <1% 101 $9K
82043 <1% 285 $9K
87205 <1% 378 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 13 $8K
85652 <1% 474 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 842 $8K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 26 $8K
90472 Immunization administration, each additional vaccine (list separately) <1% 325 $7K
87147 <1% 296 $7K
80050 General health panel <1% 82 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 471 $7K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 142 $7K
82746 <1% 126 $7K
86618 <1% 194 $6K
87653 <1% 153 $6K
83615 <1% 222 $5K
G0475 Hiv antigen/antibody, combination assay, screening <1% 120 $5K
96367 <1% 140 $5K
36600 <1% 197 $4K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 16 $4K
87210 <1% 132 $4K
85651 <1% 156 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 15 $4K
87522 Neg quan hep c or qual rna <1% 30 $4K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 383 $4K
Q3014 Telehealth originating site facility fee <1% 110 $3K
82550 <1% 89 $3K
74019 <1% 42 $3K
84550 <1% 90 $2K
87081 <1% 85 $2K
J2704 Injection, propofol, 10 mg <1% 432 $2K
96127 <1% 85 $2K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 89 $2K
82274 <1% 77 $2K
84156 <1% 49 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 41 $2K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 78 $2K
82950 <1% 69 $2K
86706 <1% 46 $2K
73110 <1% 16 $2K
59025 Fetal non-stress test <1% 18 $2K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 69 $2K
92551 <1% 101 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 38 $1K
99173 <1% 86 $1K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 140 $1K
86038 <1% 43 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 256 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 33 $1K
73502 <1% 18 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 165 $1K
82248 <1% 31 $1K
80143 <1% 130 $1K
J3490 Unclassified drugs <1% 1,763 $988.40
J2060 Injection, lorazepam, 2 mg <1% 223 $932.91
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 123 $887.99
84100 <1% 37 $728.10
80076 <1% 17 $591.65
90710 <1% 19 $488.11
90715 <1% 12 $478.36
82565 <1% 13 $469.85
84520 <1% 13 $446.64
J7510 Prednisolone oral, per 5 mg <1% 12 $391.06
90686 <1% 79 $377.77
90671 <1% 63 $298.04
86431 <1% 14 $246.51
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 13 $202.61
86617 <1% 14 $151.54
J3010 Injection, fentanyl citrate, 0.1 mg <1% 214 $147.33
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 15 $43.42
90648 <1% 50 $21.38
J3370 Injection, vancomycin hcl, 500 mg <1% 18 $19.17
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 13 $0.02
90723 0% 46 $0.00
90680 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialQUINONES, KATHLEEN (INTERIM VP FINANCE)
Parent organizationWEST VIRGINIA UNIVERSITY HOSPITALS EAST INC
Same official

Other billing entities under QUINONES, KATHLEEN

Full network →
ProviderLocationPaid
Billings ClinicBillings, MT$53.85M
City Hospital, INCMartinsburg, WV$41.06M
Billings ClinicBillings, MT$15.71M
Billings ClinicBillings, MT$3.32M
Billings ClinicBillings, MT$2.99M
Billings ClinicBillings, MT$2.40M
Billings ClinicCody, WY$110K
Billings ClinicBillings, MT$97K
Billings ClinicBillings, MT$20K
Billings ClinicLivingston, MT$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.